Patent Assignment
Reel/Frame 060242/0960
Merger
Recorded: 2022-04-07
Pages: 22
Assignor
NOVMETAHEALTH CO., LTD.
Executed: 2022-03-11
Assignee
NOVMETAPHARMA CO., LTD.
13F, 727, EONJU-RO, GANGNAM-GU, SEOUL, 06050, KOREA, REPUBLIC OF
Covered Properties
(3)
Novel Aryl Ethene Derivative and Pharmaceutical Composition Containing Same as Active Ingredient
Method for the Treatment of Pancreatitis
Method for Treatment of Cytokine Release Syndrome
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 11, 2020
From: HWANG, SUNG YEOUN; CHO, SUNG JIN; KIM, JINA; CHIN, JUNGWOOK
To: DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION; KYUNGPOOK NATIONAL UNIVERSITY HOSPITAL; KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
Reel/Frame 054619/0157 →
Assignment of Assignor's Interest
Aug 4, 2021
From: LEE, IN-KYU; JEON, JAE-HAN; CHANDA, DIPANJAN; CHOI, EUN JUNG
To: NOVMETAHEALTH CO., LTD.
Reel/Frame 057077/0918 →
Assignment of Assignor's Interest
Jan 6, 2022
From: DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION; KYUNGPOOK NATIONAL UNIVERSITY HOSPITAL; KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
To: NOVMETAHEALTH CO., LTD.
Reel/Frame 059202/0189 →
Assignment of Assignor's Interest
Oct 6, 2022
From: LEE, HEON JONG; JUNG, HOE YUNE; LEE, IN-KYU; JEON, JAE-HAN
To: NOVMETAPHARMA CO., LTD.
Reel/Frame 061339/0253 →